Literature DB >> 16010361

Design and synthesis of aromatic inhibitors of anthranilate synthase.

Richard J Payne1, Miguel D Toscano, Esther M M Bulloch, Andrew D Abell, Chris Abell.   

Abstract

Aromatic analogues of chorismate were synthesised as potential inhibitors of anthranilate synthase. Molecular modelling using GOLD2.1 showed that these analogues docked into the active site of Serratia marcescens anthranilate synthase in the same conformation as chorismate. Most compounds were found to be micromolar inhibitors of S. marcescens anthranilate synthase. The most potent analogue, 3-(1-carboxy-ethoxy)-4-hydroxybenzoate (K(I) 3 microM), included a lactyl ether side chain. This appears to be a good replacement for the enol-pyruvyl side chain of chorismate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010361     DOI: 10.1039/b503802b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

1.  Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis.

Authors:  Zheng Liu; Feng Liu; Courtney C Aldrich
Journal:  J Org Chem       Date:  2015-06-16       Impact factor: 4.354

2.  Expanding the results of a high throughput screen against an isochorismate-pyruvate lyase to enzymes of a similar scaffold or mechanism.

Authors:  Kathleen M Meneely; Qianyi Luo; Andrew P Riley; Byron Taylor; Anuradha Roy; Ross L Stein; Thomas E Prisinzano; Audrey L Lamb
Journal:  Bioorg Med Chem       Date:  2014-09-16       Impact factor: 3.641

3.  Synthesis of Transition-State Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-Dihydrodiol.

Authors:  Xiao-Kang Zhang; Feng Liu; William D Fiers; Wen-Mei Sun; Jun Guo; Zheng Liu; Courtney C Aldrich
Journal:  J Org Chem       Date:  2017-03-17       Impact factor: 4.354

Review 4.  The TB Structural Genomics Consortium: a decade of progress.

Authors:  Nicholas Chim; Jeff E Habel; Jodie M Johnston; Inna Krieger; Linda Miallau; Ramasamy Sankaranarayanan; Robert P Morse; John Bruning; Stephanie Swanson; Haelee Kim; Chang-Yub Kim; Hongye Li; Esther M Bulloch; Richard J Payne; Alexandra Manos-Turvey; Li-Wei Hung; Edward N Baker; J Shaun Lott; Michael N G James; Thomas C Terwilliger; David S Eisenberg; James C Sacchettini; Celia W Goulding
Journal:  Tuberculosis (Edinb)       Date:  2011-01-17       Impact factor: 3.131

5.  Synthesis of novel ligands targeting phenazine biosynthesis proteins as a strategy for antibiotic intervention.

Authors:  Nikolaus Guttenberger; Thomas Schlatzer; Mario Leypold; Sebastian Tassoti; Rolf Breinbauer
Journal:  Monatsh Chem       Date:  2017-11-30       Impact factor: 1.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.